• 1. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 2. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 3. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 5. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Phenyl-1,3-oxazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Oxazoles Phenyl-1,3-oxazoles

Introduction to 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine (CAS No. 408352-90-9)

1-(2-Phenyl-1,3-oxazol-4-yl)methanamine, identified by its Chemical Abstracts Service (CAS) number 408352-90-9, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the oxazole derivatives class, which is well-documented for its diverse biological activities and potential therapeutic applications. The structural framework of 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine incorporates a phenyl ring and an oxazole moiety, both of which are known to contribute to its unique chemical properties and biological interactions.

The oxazole ring, a five-membered heterocyclic structure containing one oxygen and one nitrogen atom, is a key pharmacophore in many bioactive molecules. Its presence in 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine not only enhances the compound's solubility and stability but also facilitates its interaction with biological targets. The phenyl group, on the other hand, provides additional hydrophobicity and can influence the compound's binding affinity to proteins and enzymes. This combination of structural features makes 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine a promising candidate for further investigation in drug discovery.

In recent years, there has been a surge in research focused on developing novel therapeutic agents with improved efficacy and reduced side effects. 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine has emerged as a compound of interest in this context due to its potential role in modulating various biological pathways. Studies have suggested that this molecule may exhibit inhibitory effects on certain enzymes and receptors involved in inflammation, cancer, and neurodegenerative diseases. The oxazole moiety, in particular, has been shown to interact with biological targets in ways that could lead to therapeutic benefits.

One of the most compelling aspects of 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine is its versatility in chemical modifications. Researchers can easily append or substitute functional groups on the phenyl ring or the oxazole ring to tailor its biological activity. This flexibility allows for the design of derivatives with enhanced potency, selectivity, and pharmacokinetic properties. For instance, modifications such as halogenation or alkylation can significantly alter the compound's interaction with biological targets, making it a valuable scaffold for structure-based drug design.

The synthesis of 1-(2-Phenyl-1,3-oxazol-4-yl)methanamine involves multi-step organic reactions that require precise control over reaction conditions and reagent selection. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets the stringent requirements for pharmaceutical applications. Techniques such as palladium-catalyzed cross-coupling reactions and nucleophilic substitution have been particularly useful in constructing the complex framework of this compound.

From a medicinal chemistry perspective, 1-(2-Phenyl-1,3-ozaXole)-4-ylmethanamine (CAS No. 408352909) represents an exciting opportunity for further exploration. Its unique structural features and potential biological activities make it a compelling candidate for preclinical and clinical studies. Researchers are currently investigating its effects on various disease models to determine its therapeutic potential. Preliminary findings suggest that this compound may have applications in treating conditions such as chronic inflammation and neurodegenerative disorders.

The growing interest in (Z)-N-(2-Hydroxyphenyl)-N'-[(E)-(4-hydroxyphenylethynylidene)]dithiocarbamide underscores the importance of innovative approaches in drug discovery. By leveraging computational modeling and high-throughput screening techniques, scientists can accelerate the process of identifying promising candidates like (Z)-N-(2-Hydroxyphenyl)-N'-[(E)-(4-hydroxyphenylethynylidene)]dithiocarbamide for further development. These advancements not only enhance efficiency but also reduce costs associated with traditional drug development pipelines.

In conclusion,(Z)-N-(2-HydroxyphenyI)-N'-[(E)-(4-hydroxyphenylethynylidene)]dithiocarbamide, CAS No. 408352909, stands out as a significant compound in pharmaceutical research due to its structural complexity, bioactivity,and synthetic versatility. Its potential applications in treating various diseases make it a valuable asset for researchers striving to develop novel therapeutic agents. As scientific understanding continues to evolve,(Z)-N-(2-HydroxyphenyI)-N'-[(E)-(4-hydroxyphenylethynylidene)]dithiocarbamide is expected to play an increasingly important role in advancing medical science.

• 33105-96-3(4-Oxazolemethanamine,2-(4-methylphenyl)-, hydrochloride (1:1))
• 877-39-4(4-methyl-2-phenyl-1,3-oxazole)
• 724412-56-0(4-Oxazolemethanamine,2-(4-bromophenyl)-)
• 885272-89-9(4-Oxazolemethanamine,2-(4-fluorophenyl)-)
• 885273-00-7(4-Oxazolemethanamine,2-(3-fluorophenyl)-)
• 885273-09-6(4-Oxazolemethanamine,2-(3-bromophenyl)-)
• 33105-95-2((2-phenyl-1,3-oxazol-4-yl)methylamine hydrochloride)
• 885273-38-1(4-Oxazolemethanamine,2-(3,4-dimethylphenyl)-)
• 885272-85-5(4-Oxazolemethanamine,2-(4-aminophenyl)-)
• 885272-87-7(C-2-(4-Methoxyphenyl)oxazol-4-ylmethylamine)